| Literature DB >> 28385633 |
Tessa E Fuhrer1, Thulani H Palpagama1, Henry J Waldvogel1, Beth J L Synek2, Clinton Turner2, Richard L Faull1, Andrea Kwakowsky3.
Abstract
Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain and plays an important role in regulating neuronal excitability. GABA reuptake from the synapse is dependent on specific transporters - mainly GAT-1, GAT-3 and BGT-1 (GATs). This study is the first to show alterations in the expression of the GATs in the Alzheimer's disease (AD) hippocampus, entorhinal cortex and superior temporal gyrus. We found a significant increase in BGT-1 expression associated with AD in all layers of the dentate gyrus, in the stratum oriens of the CA2 and CA3 and the superior temporal gyrus. In AD there was a significant decrease in GAT-1 expression in the entorhinal cortex and superior temporal gyrus. We also found a significant decrease in GAT-3 immunoreactivity in the stratum pyramidale of the CA1 and CA3, the subiculum and entorhinal cortex. These observations indicate that the expression of the GATs shows brain-region- and layer-specific alterations in AD, suggesting a complex activation pattern of different GATs during the course of the disease.Entities:
Keywords: Alzheimer’s disease; GABA; GABA transporters; human brain
Mesh:
Substances:
Year: 2017 PMID: 28385633 DOI: 10.1016/j.neuroscience.2017.03.041
Source DB: PubMed Journal: Neuroscience ISSN: 0306-4522 Impact factor: 3.590